Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

Author: Yamashita M.   Rosser C.J.   Zhou J.H.   Zhang X.Q.   Connor R.J.   Engler H.   Maneval D.C.   Karashima T.   Czerniak B.A.   Dinney C.P.   Benedict W.F.   Hsieh J.T.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.4, 2003-07, pp. : 313-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content